In order to find new therapeutic methods and to understand their underlying mechanisms for urological disorders, International Neurourology Journal (INJ) has tried to recruit valuable articles through a special issue. In the second special issue of INJ, we have tried new attempts to overcome urinary tract disorders.Alpha 1-adrenergic receptor (α1-AR) antagonists have been used to improve lower urinary tract symptoms in an overactive bladder (OAB) [1-3]. In this issue, the add-on therapy of the α1-AR antagonists, tamsulosin and naftopidil, were tried to improve the efficacy of α1-AR antagonists on OAB symptoms. In this animal study, the enhancing effects of combination therapy of tamsulosin and naftopidil were not observed. These controversial results might be ascribed to differences in receptor affinities or animal models [4,5]. Continuous studies of the add-on therapy, however, might provide opportunities to find a new modality for the treatment of intractable urological disorders.The circadian rhythm is an important clue for the maintenance of human health, and disruption of the circadian rhythm exerts adverse effects on health, including memory function [6-8]. In this study, the authors evaluated the circadian rhythm dependence of the effects of treadmill exercise on memory function in relation to neurogenesis. Zeitgeber is an external biological rhythm in responses to endogenous cycles which cue various actions in plants and animals [9]. Light, melatonin, and physical activity are well known zeitgebers. Light was used as the zeitgeber in this study, and the authors demonstrated that memory enhancing effect of treadmill exercise appeared more potent when exercising at daytime or evening than when exercising at dawn. These results suggest the possibility that treatment efficacy also depends on the circadian rhythm changes. Studies on the development of urological diseases according to the circadian rhythm changes may provide a new area for improving therapeutic effect.The purpose of INJ is not simply to store or deliver knowledge, but to constantly explore the possibility of developing new therapies. These attempts by INJ will enable the development of new therapies for urological diseases. The Editorial Board of INJ would like to acknowledge gratitude to the authors for the valuable articles submitted to the second special issue of INJ.